Disclosure statement
Hugo Jimenez has nothing to disclose. Sambad Sharma has nothing to disclose. Kimberly Sheffield has nothing to disclose. Kojo Agyemang has nothing to disclose. Allan Johansen has nothing to disclose. Carl Blackman reports that he has provided a loan to TheraBionic Inc. Kounosuke Watabe has nothing to disclose.
Alexandre Barbault reports other from TheraBionic Inc., other from TheraBionic GmbH, outside the submitted work; In addition, Dr. Barbault has a patent European Patent # 2139557 licensed to TheraBionic Inc., a patent U.S. patent # 8.977.365 B2 licensed to TheraBionic Inc., a patent Australian patent # 2008232041 licensed to TheraBionic Inc., a patent Brazil patent # PI0810084-5 licensed to TheraBionic Inc., a patent Canada patent # 2,682,322 licensed to TheraBionic Inc., a patent China patent # ZL 200880009864.4 licensed to TheraBionic Inc., a patent Macau patent # J/001431 licensed to TheraBionic Inc., a patent Israel patent # 201099 licensed to TheraBionic Inc., a patent Japan patent # 5435240 licensed to TheraBionic Inc., a patent Korea patent # 10-1478582 licensed to TheraBionic Inc., a patent Mexico patent # 318857 licensed to TheraBionic Inc., a patent Russia patent # 2594824 licensed to TheraBionic Inc., a patent Saudi Arabia patent # 3075 licensed to TheraBionic Inc., a patent Singapore patent # 155671 licensed to TheraBionic Inc., a patent South Africa patent # 2009/06700 licensed to TheraBionic Inc., and a patent United Arab Emirates patent # P849/09 licensed to TheraBionic Inc.
Boris Pasche reports other from TheraBionic Inc., other from TheraBionic GmbH, other from Rafael Holdings, Inc., outside the submitted work; In addition, Dr. Pasche has a patent Europe # 2139557 licensed to TheraBionic Inc., a patent U.S. # 8.977.365 B2 licensed to TheraBionic Inc., a patent Australia # 2008232041 licensed to TheraBionic Inc., a patent Brazil # PI0810084-5 licensed to TheraBionic Inc., a patent Canada # 2,682,322 licensed to TheraBionic Inc., a patent China # ZL 200880009864.4 licensed to TheraBionic Inc., a patent Macau # J/001431 licensed to TheraBionic Inc., a patent Israel # 201099 licensed to TheraBionic Inc., a patent Japan # 5435240 licensed to TheraBionic Inc., a patent Korea # 10-1478582 licensed to TheraBionic Inc., a patent Mexico # 318857 licensed to TheraBionic Inc., a patent Russia # 2594824 licensed to TheraBionic Inc., a patent Saudi Arabia # 3075 licensed to TheraBionic Inc., a patent Singapore # 155671 licensed to TheraBionic Inc., a patent South Africa # 2009/06700 licensed to TheraBionic Inc., and a patent United Arab Emirates # P849/09 licensed to TheraBionic Inc.
Additional information
Funding
Notes on contributors
Hugo Jimenez
Hugo Jimenez PhD, is a Post-Doctoral Research Fellow in the Department of Cancer Biology, Wake Forest Baptist Medical Center, North Carolina, USA
Sambad Sharma
Sambad Sharma PhD, is a Post-Doctoral Research Fellow in the Department of Cancer Biology, Wake Forest Baptist Medical Center, North Carolina, USA
Kimberly Sheffield
Kimberly Sheffield MS, is a Research Assistant in the Department of Cancer Biology, Wake Forest Baptist Medical Center, North Carolina, USA
Kojo Agyemang
Kojo Agyemang MS, is a doctoral graduate student in the Department of Cancer Biology, Wake Forest Baptist Medical Center, North Carolina, USA
Allan Johansen
Allan Johansen Msc, is a doctoral graduate student in the Department of Cancer Biology, Wake Forest Baptist Medical Center, North Carolina, USA
Carl Blackman
Carl Blackman PhD, is an Adjunct Professor in the Department of Cancer Biology, Wake Forest Baptist Medical Center, North Carolina, USA
Kounosuke Watabe
Kounosuke Watabe PhD, is a Professor in the Department of Cancer Biology, Wake Forest Baptist Medical Center, North Carolina, USA
Alexandre Barbault
Alexandre Barbault is CEO, TheraBionic Gmbh, Ettlingen, Germany
Boris Pasche
Boris Pasche MD PhD, is the Chairman of the Department of Cancer Biology and Director of the Comprehensive Cancer Center at Wake Forest Baptist Medical Center, North Carolina, USA; CEO of TheraBionic Inc. and co-CEO of TheraBionic GmbH